Cuilin Zhang is Chair Professor on Women's Health at the Department of Obstetrics and Gynaecology (National University of Singapore [NUS] Yong Loo Lin School of Medicine, Singapore) and the founding D...

Across many domains, sex and gender disparities persist, partly due to the fact that women's lived experiences remain unseen. This is true in medicine, where females are more likely to experience misd...

This analysis underscores the potential for countries to improve female-dominant health outcomes by optimising the use of existing socioeconomic resources. The inefficiencies reflect unrealised but ac...

2025 marks the 30th anniversary of the adoption of the Beijing Declaration and Platform for Action, which provides a roadmap towards gender equality. While some progress has been made over the years, ...

Ben sits down with Allisyn Moran, Department of Maternal, Newborn, Child and Adolescent Health and Ageing at WHO, to discuss the newly published maternal wellbeing framework developed by WHO and colla...

Read the current issue of The Lancet Microbe, providing a destination for the best microbiology-focused clinical research

Editors at The Lancet Obstetrics, Gynaecology, & Women’s Health, in conversation with the journal’s authors, researchers, policymakers, economists, politicians, and others who share a common passi...

The global female prison population has risen sharply since 2000, largely due to punitive responses to poverty and drug-related offences. There are no robust global data on the number of pregnant or b...

Despite well-established health-care systems in many high-income and middle-income regions, persistent gaps in representation, access, and care continue to undermine equity in cardiovascular health, r...

Stigma around mifepristone is stopping studies, experts in reproductive health claim in Lancet opinion piece A drug used in medical abortions could help prevent women at high risk of breast cancer from developing the disease, according to an international group of doctors and scientists. However, “stigma” around mifepristone is stopping pharmaceutical companies from investigating its potential as a new treatment doctors could offer to reduce the risk of breast cancer, they say. Continue reading...

Breast cancer is the leading cause of cancer-related deaths among women globally. Yet, current management strategies emphasise detection and treatment over primary prevention. For groups at high risk ...

Semantic entropy offers a robust and scalable method to identify uncertain or potentially misleading outputs from LLMs. Semantic entropy could support safer artificial intelligence-assisted clinical d...

In a field in which global guidance often dictates local practice, the landmark randomised trial published in The Lancet Obstetrics, Gynaecology, & Women's Health by Herbert Kayiga and colleagues bold...

Early IUD insertion after medical treatment of first trimester incomplete abortions was non-inferior to standard IUD insertion with respect to expulsion and continuation rates. The factors associated ...

World Breastfeeding Week (Aug 1–7) highlights and celebrates breastfeeding as a powerful foundation for lifelong health, development, and equity, and calls for support for every mother who wishes to b...